Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor antigen (EBV-positive)
- Molecular classification
- Viral protein, Non-coding RNA, Antigen
01
Overview
EBV-positive tumor antigens are viral proteins and RNAs expressed in human tumors infected with Epstein-Barr virus (EBV). These antigens, including EBERs, LMPs, EBNAs, and BARF1, contribute to oncogenesis by promoting cell proliferation, inhibiting apoptosis, modulating immune responses, and inducing epigenetic changes. Their presence is a key diagnostic feature and a potential target for immunotherapy.
- Other names
- EBV tumor antigensEBV-associated tumor antigensEpstein-Barr virus tumor antigensLMP1LMP2ALMP2BEBNA1EBNA2EBER1EBER2BARF1miR-BARTs
02
Mechanism of action
Immune stimulation through antigen presentation; Inhibition of viral protein function
03
Biological functions
Cell proliferationApoptosis inhibitionImmune modulationOncogenesisEpigenetic modification
04
Disease associations
CancerLymphomaNasopharyngeal carcinomaGastric carcinoma
05
Safety considerations
Immune escape mechanisms (e.g., PD-L1 upregulation)Potential for off-target effects in vaccine strategies
06
Biomarkers
EBER expression (in situ hybridization)LMP1 expressionLMP2 expressionBARF1 expressionEBNA expressionPD-L1 expression
Beyond the preview
Go deeper on Tumor antigen (EBV-positive).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tumor antigen (EBV-positive).